Colorectal cancer stem cells exhibit enhanced CD44, CD133 and Lgr5 expression (Zeilstra et al., 2008); therefore, loss of Fzd7 may initiate tumorigenesis in the colon. This evidence concerns the gene CD44 and colorectal cancer.